Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1860 of 6351
-
New study aims to cut side effects in throat cancer treatment
Disease control Recruiting nowThis is a prospective, phase II, stratified single arm investigation for favorable prognosis in p16+ oropharynx cancer patients with either node negative or malignant neck adenopathy with lymphoscintigraphy mapping confined to the ipsilateral neck.
Phase 2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Smart insulin pump aims to take the guesswork out of diabetes management
Disease control CompletedAn artificial pancreas (AP) is a control system for automatic insulin delivery. The investigators have implemented a missed meal bolus detection algorithm for use within an AP control system. If a meal is detected that was not reported by the user, the system shall calculate the …
Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug trial offers hope for rare brain disease
Disease control Recruiting nowFosigotifator is an investigational drug being researched for the treatment of Vanishing White Matter disease in adult, pediatric and infant participants. This is a 201-week, open-label, multiple cohort study enrolling adults, pediatric and infant participants with Vanishing Whit…
Phase 1/2 • Sponsor: Calico Life Sciences LLC • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Inhaled treprostinil shows promise for exercise capacity in PAH-ILD patients
Disease control CompletedThe purpose of this research study is to find out more about the drug treprostinil via inhaler and the mechanisms of why patients with pulmonary arterial hypertension related to Interstitial Lung disease (PAH-ILD) have limitations during exercise. The investigator is studying tre…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can shingrix shield HIV patients from shingles?
Vaccine Recruiting nowBackground: Shingles is a painful, blistering rash caused by the same virus that causes chickenpox. Shingrix is a vaccine approved to prevent shingles in healthy adults over age 50 and in immunocompromised adults over age 18. Researchers want to learn more about how people with …
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Aug 15, 2026 00:00 UTC
-
New pill could help when blood pressure meds Aren't enough
Disease control CompletedA Phase 2 trial to evaluate the blood pressure-lowering effect of lorundrostat an aldosterone synthase inhibitor (ASI), administered as an add-on to a standardized anti-hypertensive (AHT) medication regimen, in subjects with hypertension.
Phase 2 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Family-Focused telehealth program aims to curb alcohol abuse in veterans
Disease control Recruiting nowImproving alcohol use disorder (AUD) treatment among Veterans is a national public health problem. The rate of AUD among Veterans is twice that of civilians, with up to 50% of Veterans having AUD. Family-based AUD programs are rarely undertaken in busy treatment clinics, and Vete…
Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could a common gut drug clear brain fog in liver patients?
Disease control CompletedThis is a pilot study designed to evaluate the efficacy and safety of nifuroxazide in the treatment of hepatic encephalopathy in patients with grade II-III hepatic encephalopathy
Phase 3 • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 26, 2026 12:44 UTC
-
Can a 3D-Printed jaw model cut surgery time for broken jaws?
Disease control OngoingThe investigators will test the hypothesis that patients randomized to the intervention (3D printing with pre-bent plate) arm have less operative room time and less time for the critical part of the procedure than patients in the control arm (no 3D printing, current standards of …
Sponsor: University of Cincinnati • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Supercharged immune cells take on Hard-to-Treat lung cancer
Disease control Recruiting nowTo determine the effect of a special preparation of cells, called tumor-infiltrating lymphocytes (TIL) stimulated with CD40L, when given with the drug nivolumab, for patients with EGFR, ALK, ROS1, or HER2-genomically altered lung cancer.
Phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can a computer help heal trauma? new study tests blended therapy for PTSD
Symptom relief Recruiting nowA Randomized Controlled Non-inferiority Trial testing if the new experimental Blended Trauma focused cognitive behavioral therapy (B-TF-CBT) for post traumatic stress disorder (PTSD), is non-inferior to gold standard control treatment Prolonged Exposure (PE). Research question a…
Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Can milk proteins stop deadly diarrhea cycles in malnourished kids?
Disease control Recruiting nowChildren in low- and middle-income countries who are hospitalized for diarrhea and also have malnutrition are at high risk for illness and death in the 6 months period following treatment for diarrhoea despite receiving current guideline recommended diarrhea management (such as o…
Phase 3 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 26, 2026 15:52 UTC
-
Radiation's hidden toll: could it link tinnitus and hearing loss in cancer survivors?
Knowledge-focused Recruiting nowThe aim of the AURACCO study is to evaluate the association between the onset of tinnitus and hearing loss in patients with locally advanced head and neck cancer treated by concomitant chemoradiotherapy or exclusive radiotherapy
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Glowing dye could help burn surgeons cut away only the dead tissue
Diagnosis OngoingThis study investigates fluorescence image-guided surgery to allow precise identification of necrotic tissue both preoperatively and intraoperatively in burn patients. Furthermore, it uses a multi-model approach to elucidate the localization of ICG in inflammation and necrosis to…
Sponsor: University of Wisconsin, Madison • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
New daily pill shows promise for controlling stubborn eczema in real life
Disease control Recruiting nowThe purpose of this study is to learn about the safety and effects of Abrocitinib in the real-life clinical setting given for the treatment of moderate to severe atopic dermatitis. Atopic dermatitis, or AD, is a long-lasting disease that causes inflammation, redness, and irritati…
Sponsor: Pfizer • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug cocktail shows promise for Hard-to-Treat breast cancer
Disease control Stopped earlyBreast cancer (BC) is the most common neoplasm in the world. In Spain, one in 8 women is diagnosed with BC. The human epidermal growth factor receptor 2 (HER2)-positive BC subtype (that represents around 20% of all BC) was associated with poor prognosis however, new therapeutic a…
Phase 2 • Sponsor: Spanish Breast Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New HIV pill shows promise in phase 3 trial
Disease control OngoingThis is a randomized, active-controlled, double-blind clinical study designed to evaluate the antiretroviral activity, safety, and tolerability of doravirine/islatravir (DOR/ISL \[MK-8591A\]) in treatment-naïve participants with human immunodeficiency virus type 1 (HIV-1) infecti…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Immunotherapy before lung surgery shows promise in early trial
Disease control CompletedThis study was conducted to evaluate the preliminary effectiveness and safety of treatment with tislelizumab alone and in combination with other investigational agents prior to surgery (neoadjuvant treatment) in adults with non-small cell lung cancer (NSCLC) that is able to be re…
Phase 2 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a lighter MS treatment keep the disease at bay?
Disease control OngoingThe investigators propose a multi-center pilot study, which aims to evaluate safety and efficacy of fumarates as de-escalation therapy in clinically stable MS patients previously treated with anti-CD20 therapy.
Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could a lesson on cancer risks save lives in underserved communities?
Prevention Recruiting nowThe University of California Davis, Comprehensive Cancer Center's (UCDCCC) Office of Community Outreach and Engagement (OCOE) serves the 19 catchment counties which approximately consists of 5 million residents. Currently, the overall catchment population cancer screening rates f…
Sponsor: University of California, Davis • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC